08 May 2024
08 May 2024
Countries such as Australia have already ceased the supply of Vaxzevria, with its use discontinued since March 2023.
The centre of gravity in the pharmaceutical industry is changing. But one common factor can help make supply chains more comprehensible, resilient and valuable: data
The increase in revenue was primarily driven by strong product sales of the cystic fibrosis drug Trikafta in ex-US markets.
Alpibectir is currently undergoing a Phase IIa proof-of-concept clinical trial in South Africa, targeting pulmonary TB patients.
The companies will utilise Broken String’s DNA break mapping platform Induce-seq for ALS research.
A new study has further supported psilocybin's potential to treat depression, which impacts around 300 million people globally.
The collaboration aims to harness computational tools to streamline the development process of XCE853.
The latest approval provides a three-month dosing alternative for young women with HR+ breast cancer.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
